Results 21 to 30 of about 98,054 (191)

Measurement, modeling and QALYs [PDF]

F1000Research, 2020
Over the past 30 years, a mainstay of health technology assessment has been the creation of modeled incremental cost-per-quality adjusted life year (QALY) claims. These are intended to inform resource allocation decisions. Unfortunately, the reliance on the construction of QALYs from generic utility scales is misplaced.
Paul C. Langley, Stephen P. McKenna
openaire   +2 more sources

Cost-effectiveness study of the MitraClip system for mitral regurgitation treatment in inoperable patients

Евразийский Кардиологический Журнал, 2021
The study aims to estimate the MitraClip system’s cost-effectiveness compared with optimal medical therapy in adult patients with inoperable mitral regurgitation and assess its impact on the budget of the Russian Federation health system.Materials and ...
E. G. Fedina, K. A. Perova, T. S. Teptsova, D. S. Shchurov   +3 more
doaj   +1 more source

On the Optimization of Bayesian D-Efficient Discrete Choice Experiment Designs for the Estimation of QALY Tariffs That Are Corrected for Nonlinear Time Preferences.

Value in Health, 2019
OBJECTIVES This article explains how to optimize Bayesian D-efficient discrete choice experiment (DCE) designs for the estimation of quality-adjusted life year (QALY) tariffs that are unconfounded by respondents' time preferences.
M. Jonker, M. Bliemer
semanticscholar   +1 more source

Pharmacoeconomic justification of the choice of specific therapy schemes for the treatment of adult patients with pulmonary arterial hypertension

Фармацевтичний журнал, 2022
Pulmonary arterial hypertension (PAH) is a progressive and debilitating disease that causes the blood vessels in the lungs to thicken and narrow, forcing the heart to pump blood through the lungs at high pressure. In recent years, a significant number
I. S. Datsenko, A. V. Kabachna
doaj   +1 more source

Pharmacoeconomic analysis of the use of tocilizumab in therapy for rheumatoid arthritis:imitation simulation

Научно-практическая ревматология, 2010
Heavy economic expenses for treatment with genetic engineering biologicals (GEB) in patients with rheumatoid arthritis (RA) determine what strategies are most optimal in terms of both their clinical efficiency and economic constituent should be sought ...
Dmitry Vladimirovich Goryachev, Sh F Erdes, E L Nasonov   +2 more
doaj   +1 more source

Economic evaluations of 13-valent pneumococcal conjugate vaccine: a systematic review

Expert Review of Vaccines, 2023
Introduction Studies on economic evaluations of the 13-valent pneumococcal conjugate vaccine (PCV13) have been increasing over the last decade. No systematic reviews have synthesized the evidence of economic evaluations of the PCV13.
Yuanze Du, Yi Wang, Ting Zhang, Juanjuan Li, Hewei Song, Yuanyuan Wang, Yifei Xu, Jingwen Cui, Ming Yang, Zengwu Wang, Xiuyun Wu, Chunping Wang   +11 more
doaj   +1 more source

Analysis of the cost-effectiveness of early diagnosis and pharmacotherapy of pulmonary arterial hypertension

Фармацевтичний журнал, 2023
Over the past decades, health policy makers have focused on early diagnosis to introduce targeted and innovative treatments. Early diagnosis of pulmonary arterial hypertension (PAH) is associated with improved long-term survival, so screening high-risk ...
I. S. Datsenko
doaj   +1 more source

QALY-time: experts’ view on the use of the quality-adjusted LIFE year in COST-effectiveness analysis in palliative care

BMC Health Services Research, 2019
Background The Quality-Adjusted Life Year (QALY) is internationally recognized as standard metric of health outcomes in cost-effectiveness analyses (CEAs) in healthcare.
Anne B. Wichmann, Lia Goltstein, Ndidi J Obihara, Madeleine R. Berendsen, M. Van Houdenhoven, R. Morrison, B. Johnston, Y. Engels, Madeleine Lia Elze Melvin Wytse Luc Ndidi Jelte Jordy Berendsen Goltstein Knol Kool Nienhuis Nies Obihar, Madeleine R. Berendsen, Lia Goltstein, E. Knol, M. Kool, Wytse Nienhuis, Luc Nies, Ndidi J Obihara, Jelte Pieksma, J. Rovers   +17 more
semanticscholar   +1 more source

Availability and Pharmacoeconomics of Insulin Therapy in Countries with the Largest Number of Diabetics

Фармакоэкономика, 2019
The aim of the review was to analyze the availability of insulin therapy and the ways to improve it in countries with the largest number of patients with diabetes. It was also aimed to assess the medical, social and economic importance of insulin therapy
S. V. Ponomarenko
doaj   +1 more source

“The trouble with QALYs…” [PDF]

Epidemiology and Psychiatric Sciences, 2007
AbstractThis paper summarises the use of QALYs in evaluating changes in mental health states, highlighting the benefits and challenges of their use in this field. The general principles underlying the QALY measure and the most common methods of measuring QALYs are discussed briefly.
Knapp, M, Mangalore, R
openaire   +2 more sources